Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

BACKGROUND: Systemic inflammation has been linked with cancer development, cancer cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree of systemic inflammation at the time of diagnosis in metastatic non-small cell lung (NSCLC) cancer patients. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafri, Syed H, Shi, Runhua, Mills, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618002/
https://www.ncbi.nlm.nih.gov/pubmed/23530866
http://dx.doi.org/10.1186/1471-2407-13-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618002/
https://www.ncbi.nlm.nih.gov/pubmed/23530866
http://dx.doi.org/10.1186/1471-2407-13-158

Ejemplares similares